| Market Cap | 19.7M 17.08M 16.14M 14.65M 27.46M 1.89B 27.62M 193M 74.45M 959M 74.02M 72.37M 3.06B | P/E 2026 * |
-1.9x | P/E 2027 * | -8.69x |
|---|---|---|---|---|---|
| Enterprise Value | 19.7M 17.08M 16.14M 14.65M 27.46M 1.89B 27.62M 193M 74.45M 959M 74.02M 72.37M 3.06B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Celsus Therapeutics PLC (ADR)
| 1 day | +0.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 21/04/2025 | |
Kameel Farag
DFI | Director of Finance/CFO | 48 | 22/10/2025 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 72 | 08/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 81 | 01/09/2015 | |
Samir Patel
BRD | Director/Board Member | 56 | 29/11/2023 |
Robert Bazemore
BRD | Director/Board Member | 58 | 17/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | -31.94% | - | - | 19.7M | |
| +1.03% | +1.21% | +48.79% | +97.65% | 1,014B | |
| +0.34% | +0.07% | +51.47% | +65.55% | 644B | |
| +0.12% | +4.62% | +21.39% | +72.57% | 464B | |
| -0.83% | +4.14% | +38.17% | +39.48% | 354B | |
| +1.39% | +3.14% | +19.76% | +25.69% | 265B | |
| +1.50% | +4.66% | +7.99% | +14.71% | 253B | |
| +0.43% | -3.81% | +37.81% | +44.35% | 203B | |
| +1.18% | -4.37% | -25.90% | -57.90% | 186B | |
| +0.83% | +1.39% | +33.21% | +95.16% | 183B | |
| Average | +0.77% | +0.96% | +25.85% | +44.14% | 396.31B | |
| Weighted average by Cap. | +0.71% | +1.41% | +34.28% | +60.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.85M -23.27M -21.99M -19.97M -37.42M -2.58B -37.65M -263M -101M -1.31B -101M -98.63M -4.16B | -20.89M -18.11M -17.11M -15.54M -29.12M -2B -29.29M -204M -78.94M -1.02B -78.49M -76.74M -3.24B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
